Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT06627413 · COMPLETED
Trial details
- NCT number
- NCT06627413
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-23
- Primary completion
- 2025-11-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.